Gerassimos A. Pangalis

7.7k total citations · 1 hit paper
174 papers, 4.7k citations indexed

About

Gerassimos A. Pangalis is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Gerassimos A. Pangalis has authored 174 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Pathology and Forensic Medicine, 99 papers in Genetics and 46 papers in Oncology. Recurrent topics in Gerassimos A. Pangalis's work include Lymphoma Diagnosis and Treatment (103 papers), Chronic Lymphocytic Leukemia Research (87 papers) and CNS Lymphoma Diagnosis and Treatment (21 papers). Gerassimos A. Pangalis is often cited by papers focused on Lymphoma Diagnosis and Treatment (103 papers), Chronic Lymphocytic Leukemia Research (87 papers) and CNS Lymphoma Diagnosis and Treatment (21 papers). Gerassimos A. Pangalis collaborates with scholars based in Greece, United States and United Kingdom. Gerassimos A. Pangalis's co-authors include Henry Rappaport, Theodoros P. Vassilakopoulos, Bharat N. Nathwani, Maria K. Angelopoulou, Marina P. Siakantaris, Christos Kittas, Meletios Α. Dimopoulos, Robert M. Bearman, Maria Dimopoulou and Y Bastion and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Gerassimos A. Pangalis

171 papers receiving 4.5k citations

Hit Papers

Clinicopathological definition of Waldenstrom's macroglob... 2003 2026 2010 2018 2003 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia
    2003 621 citations Gerassimos A. Pangalis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerassimos A. Pangalis Greece 34 2.6k 2.4k 1.3k 1.2k 1.1k 174 4.7k
Emilio Montserrat Spain 30 2.0k 0.8× 2.4k 1.0× 1.1k 0.9× 1.2k 1.0× 1.4k 1.3× 84 4.2k
Eckhart Weidmann Germany 38 2.1k 0.8× 1.3k 0.5× 2.0k 1.5× 1.3k 1.0× 770 0.7× 111 5.0k
Thierry Lamy France 41 2.6k 1.0× 2.1k 0.9× 2.3k 1.8× 2.6k 2.1× 1.9k 1.7× 177 6.4k
Luca Laurenti Italy 37 1.4k 0.5× 2.5k 1.0× 840 0.7× 1.7k 1.4× 1.1k 1.1× 220 4.8k
Dolores Caballero Spain 36 2.0k 0.8× 1.1k 0.4× 1.8k 1.4× 1.1k 0.9× 1.7k 1.6× 137 4.5k
Corrado Tarella Italy 41 2.8k 1.1× 1.5k 0.6× 2.8k 2.2× 1.3k 1.0× 2.5k 2.3× 213 6.2k
Michinori Ogura Japan 43 3.2k 1.3× 1.8k 0.7× 3.0k 2.3× 2.2k 1.7× 1.5k 1.4× 223 7.3k
Lisa M. Rimsza United States 42 3.5k 1.4× 1.6k 0.6× 2.6k 2.1× 1.2k 1.0× 1.2k 1.1× 199 6.2k
Julio Delgado Spain 35 1.3k 0.5× 1.6k 0.7× 1.0k 0.8× 939 0.8× 1.1k 1.0× 195 3.6k
Hartmut Kirchner Germany 32 1.7k 0.7× 826 0.3× 1.9k 1.5× 1.2k 0.9× 1.0k 1.0× 117 5.0k

Countries citing papers authored by Gerassimos A. Pangalis

Since Specialization
Citations

This map shows the geographic impact of Gerassimos A. Pangalis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerassimos A. Pangalis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerassimos A. Pangalis more than expected).

Fields of papers citing papers by Gerassimos A. Pangalis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerassimos A. Pangalis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerassimos A. Pangalis. The network helps show where Gerassimos A. Pangalis may publish in the future.

Co-authorship network of co-authors of Gerassimos A. Pangalis

This figure shows the co-authorship network connecting the top 25 collaborators of Gerassimos A. Pangalis. A scholar is included among the top collaborators of Gerassimos A. Pangalis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerassimos A. Pangalis. Gerassimos A. Pangalis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sachanas, Sotirios, Gerassimos A. Pangalis, Anastasios Koutsopoulos, et al.. (2020). Long Term Response of a Patient with Lymphangiomatosis under Bevacizumab Therapy- A Case Report. 6(5). 1 indexed citations
2.
Siakantaris, Marina P., Kimon V. Argyropoulos, Vasiliki Papadopoulou, et al.. (2015). Cytomegalovirus Meningoencephalitis After Rituximab Treatment for Primary Central Nervous System Lymphoma. The Neurologist. 19(2). 35–37. 6 indexed citations
3.
Angelopoulou, Maria K., Christina Kalpadakis, Gerassimos A. Pangalis, Marie‐Christine Kyrtsonis, & Theodoros P. Vassilakopoulos. (2013). Nodal marginal zone lymphoma. Leukemia & lymphoma. 55(6). 1240–1250. 15 indexed citations
4.
Diamantopoulos, Panagiotis, Marina Mantzourani, Nikolaos Spanakis, et al.. (2013). Survivin Messenger RNA Levels in Epstein-Barr Virus–Positive Patients With Leukemic Low-Grade B-Cell Lymphomas Expressing the Latent Membrane Protein 1: Evidence of Apoptotic Function?. Clinical Lymphoma Myeloma & Leukemia. 14(1). 56–60. 2 indexed citations
5.
Levidou, Georgia, Τατιάνα Τζένου, Marie‐Christine Kyrtsonis, et al.. (2013). The Role of CXC-Chemokine IL-8, IL-6 and CXCR2 Receptor in Lymphoplasmacytic Lymphoma: Correlations with Microvascular Characteristics and Clinical Features. 2(2). 110–118. 1 indexed citations
6.
Sachanas, Sotirios, Georgia Levidou, Maria K. Angelopoulou, et al.. (2013). Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 55(3). 571–582. 7 indexed citations
7.
Kalpadakis, Christina, Gerassimos A. Pangalis, Theodoros P. Vassilakopoulos, et al.. (2008). Non-gastric extra-nodal marginal zone lymphomas–a single centre experience on 76 patients. Leukemia & lymphoma. 49(12). 2308–2315. 21 indexed citations
8.
Pangalis, Gerassimos A. & Panayiotis Panayiotidis. (2006). Lymphoma: Methods and Protocols. European Journal Of Haematology. 77(1). 88–88. 9 indexed citations
9.
Vassilakopoulos, Theodoros P., Marie‐Christine Kyrtsonis, Gianpaolo Nadali, et al.. (2006). Serum levels of soluble syndecan-1 in Hodgkin's lymphoma.. PubMed. 25(6C). 4743–6. 26 indexed citations
10.
Moyssakis, Ioannis, et al.. (2005). Reversible dilated cardiomyopathy associated with amphotericin B treatment. International Journal of Antimicrobial Agents. 25(5). 444–447. 13 indexed citations
11.
Vassilakopoulos, Theodoros P. & Gerassimos A. Pangalis. (2000). Application of a Prediction Rule to Select which Patients Presenting with Lymphadenopathy Should Undergo a Lymph Node Biopsy. Medicine. 79(5). 338–347. 31 indexed citations
12.
Pangalis, Gerassimos A.. (1995). Malignant lymphomas : biology and treatment : an update. Springer eBooks. 1 indexed citations
13.
Korkolopoulou, P., et al.. (1994). B-cell Lymphoma of Large Multilobated Type: An Immunohistochemical Study of 8 Cases and Review of the Literature. Leukemia & lymphoma. 13(1-2). 151–159. 5 indexed citations
14.
Pangalis, Gerassimos A., T. P. Vassilakopoulos, Vassiliki A. Boussiotis, & P Fessas. (1993). Clinical approach to lymphadenopathy.. PubMed. 20(6). 570–82. 66 indexed citations
15.
16.
Kittas, Christos, et al.. (1990). Expression of c-myc p62 Protein in Non-Hodgkin's Lymphomas. Leukemia & lymphoma. 1(3-4). 241–247. 7 indexed citations
17.
18.
Pangalis, Gerassimos A., et al.. (1985). Poly(A)-Polymerase Activity in Chronic Lymphocytic Leukemia of the B Cell Type. Acta Haematologica. 74(1). 31–34. 16 indexed citations
19.
Pangalis, Gerassimos A., Bharat N. Nathwani, Henry Rappaport, & Robert B. Rosen. (1979). Acute lymphoblastic leukemia.The significance of nuclear convolutions. Cancer. 43(2). 551–557. 8 indexed citations
20.
Nathwani, Bharat N., Henry Rappaport, Edgar M. Moran, Gerassimos A. Pangalis, & Hun Kim. (1978). Malignant lymphoma arising in angio-immunoblastic lymphadenopathy. Cancer. 41(2). 578–606. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilio Montserrat Breakdown of academic impact, for papers by Eckhart Weidmann Breakdown of academic impact, for papers by Thierry Lamy Breakdown of academic impact, for papers by Luca Laurenti Breakdown of academic impact, for papers by Dolores Caballero Breakdown of academic impact, for papers by Corrado Tarella Breakdown of academic impact, for papers by Michinori Ogura Breakdown of academic impact, for papers by Lisa M. Rimsza Breakdown of academic impact, for papers by Julio Delgado Breakdown of academic impact, for papers by Hartmut Kirchner
Rankless by CCL
2026